C7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma.

Detalhes bibliográficos
Autor(a) principal: Correa, Ana Beatriz Guimarães
Data de Publicação: 2011
Outros Autores: Crawford, Lindsey B, Figueiredo, Carlos R, Gimenes, Karina Panizzi, Pinto, Lorena Ana, Grassi, Maria Fernanda Rios, Feuer, Gerold, Travassos, Luiz Rodolpho, Caires, Antonio Carlos Fávero, Rodrigues, Elaine G, Marriott, Susan J
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/8497
Resumo: Universidade Federal de São Paulo. UNIFESP-EPM. Unidade de Oncologia Experimental, Departamento de Microbiologia, Imunologia e Parasitologia. São Paulo, SP, Brasil
id CRUZ_2c22e0e69aecfd29b17e53091c3285af
oai_identifier_str oai:www.arca.fiocruz.br:icict/8497
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Correa, Ana Beatriz GuimarãesCrawford, Lindsey BFigueiredo, Carlos RGimenes, Karina PanizziPinto, Lorena AnaGrassi, Maria Fernanda RiosFeuer, GeroldTravassos, Luiz RodolphoCaires, Antonio Carlos FáveroRodrigues, Elaine GMarriott, Susan J2014-10-03T18:50:40Z2014-10-03T18:50:40Z2011CORREA, A. B. G. et al. C7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma. Viruses, v. 3, n. 7, p. 1041-1058, 2011.1999-491510.3390/v3071041https://www.arca.fiocruz.br/handle/icict/8497engMDPIC7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma.info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleUniversidade Federal de São Paulo. UNIFESP-EPM. Unidade de Oncologia Experimental, Departamento de Microbiologia, Imunologia e Parasitologia. São Paulo, SP, BrasilSUNY Upstate Medical University. Syracuse Department of Microbiology and Immunology. New York, USAUniversidade Federal de São Paulo. UNIFESP-EPM. Unidade de Oncologia Experimental, Departamento de Microbiologia, Imunologia e Parasitologia. São Paulo, SP, BrasilUniversidade Federal de São Paulo. UNIFESP-EPM. Unidade de Oncologia Experimental, Departamento de Microbiologia, Imunologia e Parasitologia. São Paulo, SP, BrasilFundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Laboratório Avançado de Saúde Pública. Salvador, BA, BrasilFundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Laboratório Avançado de Saúde Pública. Salvador, BA, BrasilHumurine Technologies. Arrow Highway, La Verne, USAUniversidade Federal de São Paulo. UNIFESP-EPM. Unidade de Oncologia Experimental, Departamento de Microbiologia, Imunologia e Parasitologia. São Paulo, SP, BrasilUniversidade de Mogi de Cruzes. Centro Interdisciplinar de Investigação Bioquímica. Mogi das Cruzes, SP, BrasilUniversidade Federal de São Paulo. UNIFESP-EPM. Unidade de Oncologia Experimental, Departamento de Microbiologia, Imunologia e Parasitologia. São Paulo, SP, BrasilBaylor College of Medicine. Department of Molecular Virology and Microbiology. Houston Texas, USAAdult T-cell leukemia/lymphoma (ATLL) is a highly aggressive disease that occurs in individuals infected with the human T lymphotropic virus type 1 (HTLV-1). Patients with aggressive ATLL have a poor prognosis because the leukemic cells are resistant to conventional chemotherapy. We have investigated the therapeutic efficacy of a biphosphinic cyclopalladated complex {Pd(2) [S(-)C(2), N-dmpa](2) (µ-dppe)Cl(2)}, termed C7a, in a patient-derived xenograft model of ATLL, and investigated the mechanism of C7a action in HTLV-1-positive and negative transformed T cell lines in vitro. In vivo survival studies in immunocompromised mice inoculated with human RV-ATL cells and intraperitoneally treated with C7a led to significantly increased survival of the treated mice. We investigated the mechanism of C7a activity in vitro and found that it induced mitochondrial release of cytochrome c, caspase activation, nuclear condensation and DNA degradation. These results suggest that C7a triggers apoptotic cell death in both HTLV-1 infected and uninfected human transformed T-cell lines. Significantly, C7a was not cytotoxic to peripheral blood mononuclear cells (PBMC) from healthy donors and HTLV-1-infected individuals. C7a inhibited more than 60% of the ex vivo spontaneous proliferation of PBMC from HTLV-1-infected individuals. These results support a potential therapeutic role for C7a in both ATLL and HTLV-1-negative T-cell lymphomas.Cyclopalladated compoundHTLV-1ATLLChemotherapyXenograft modelApoptosisApoptose/efeitos de drogasComplexos de Coordenação/farmacologiaVírus 1 Linfotrópico T Humano/crescimento & desenvolvimentoLeucemia-Linfoma de Células T do Adulto/quimioterapiaPaládio/farmacologiaFeniramina/análogos & derivadosAnimaisLinhagem Celular TransformadaSobrevivência Celular/efeitos de drogasCitocromos c/metabolismoCitometria de FluxoHumanosLeucemia-Linfoma de Células T do Adulto/virologiaCamundongosCamundongos SCIDFeniramina/farmacologiaOrganismos Livres de Patógenos EspecíficosEnsaios Antitumorais Modelo de Xenoenxertoinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-81914https://www.arca.fiocruz.br/bitstream/icict/8497/1/license.txt7d48279ffeed55da8dfe2f8e81f3b81fMD51ORIGINALCorreia ABG C7a a Biphosphinic....pdfCorreia ABG C7a a Biphosphinic....pdfapplication/pdf780743https://www.arca.fiocruz.br/bitstream/icict/8497/2/Correia%20ABG%20C7a%20a%20Biphosphinic....pdf005cdd6045b4745755308b3f78929ee9MD52TEXTCorreia ABG C7a a Biphosphinic....pdf.txtCorreia ABG C7a a Biphosphinic....pdf.txtExtracted texttext/plain52139https://www.arca.fiocruz.br/bitstream/icict/8497/3/Correia%20ABG%20C7a%20a%20Biphosphinic....pdf.txt7d16bcc83602c2e7bffdae335c6e31deMD53icict/84972023-03-15 14:33:22.094oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-15T17:33:22Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv C7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma.
title C7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma.
spellingShingle C7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma.
Correa, Ana Beatriz Guimarães
Cyclopalladated compound
HTLV-1
ATLL
Chemotherapy
Xenograft model
Apoptosis
Apoptose/efeitos de drogas
Complexos de Coordenação/farmacologia
Vírus 1 Linfotrópico T Humano/crescimento & desenvolvimento
Leucemia-Linfoma de Células T do Adulto/quimioterapia
Paládio/farmacologia
Feniramina/análogos & derivados
Animais
Linhagem Celular Transformada
Sobrevivência Celular/efeitos de drogas
Citocromos c/metabolismo
Citometria de Fluxo
Humanos
Leucemia-Linfoma de Células T do Adulto/virologia
Camundongos
Camundongos SCID
Feniramina/farmacologia
Organismos Livres de Patógenos Específicos
Ensaios Antitumorais Modelo de Xenoenxerto
title_short C7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma.
title_full C7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma.
title_fullStr C7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma.
title_full_unstemmed C7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma.
title_sort C7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma.
author Correa, Ana Beatriz Guimarães
author_facet Correa, Ana Beatriz Guimarães
Crawford, Lindsey B
Figueiredo, Carlos R
Gimenes, Karina Panizzi
Pinto, Lorena Ana
Grassi, Maria Fernanda Rios
Feuer, Gerold
Travassos, Luiz Rodolpho
Caires, Antonio Carlos Fávero
Rodrigues, Elaine G
Marriott, Susan J
author_role author
author2 Crawford, Lindsey B
Figueiredo, Carlos R
Gimenes, Karina Panizzi
Pinto, Lorena Ana
Grassi, Maria Fernanda Rios
Feuer, Gerold
Travassos, Luiz Rodolpho
Caires, Antonio Carlos Fávero
Rodrigues, Elaine G
Marriott, Susan J
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Correa, Ana Beatriz Guimarães
Crawford, Lindsey B
Figueiredo, Carlos R
Gimenes, Karina Panizzi
Pinto, Lorena Ana
Grassi, Maria Fernanda Rios
Feuer, Gerold
Travassos, Luiz Rodolpho
Caires, Antonio Carlos Fávero
Rodrigues, Elaine G
Marriott, Susan J
dc.subject.en.pt_BR.fl_str_mv Cyclopalladated compound
HTLV-1
ATLL
Chemotherapy
Xenograft model
Apoptosis
topic Cyclopalladated compound
HTLV-1
ATLL
Chemotherapy
Xenograft model
Apoptosis
Apoptose/efeitos de drogas
Complexos de Coordenação/farmacologia
Vírus 1 Linfotrópico T Humano/crescimento & desenvolvimento
Leucemia-Linfoma de Células T do Adulto/quimioterapia
Paládio/farmacologia
Feniramina/análogos & derivados
Animais
Linhagem Celular Transformada
Sobrevivência Celular/efeitos de drogas
Citocromos c/metabolismo
Citometria de Fluxo
Humanos
Leucemia-Linfoma de Células T do Adulto/virologia
Camundongos
Camundongos SCID
Feniramina/farmacologia
Organismos Livres de Patógenos Específicos
Ensaios Antitumorais Modelo de Xenoenxerto
dc.subject.decs.pt_BR.fl_str_mv Apoptose/efeitos de drogas
Complexos de Coordenação/farmacologia
Vírus 1 Linfotrópico T Humano/crescimento & desenvolvimento
Leucemia-Linfoma de Células T do Adulto/quimioterapia
Paládio/farmacologia
Feniramina/análogos & derivados
Animais
Linhagem Celular Transformada
Sobrevivência Celular/efeitos de drogas
Citocromos c/metabolismo
Citometria de Fluxo
Humanos
Leucemia-Linfoma de Células T do Adulto/virologia
Camundongos
Camundongos SCID
Feniramina/farmacologia
Organismos Livres de Patógenos Específicos
Ensaios Antitumorais Modelo de Xenoenxerto
description Universidade Federal de São Paulo. UNIFESP-EPM. Unidade de Oncologia Experimental, Departamento de Microbiologia, Imunologia e Parasitologia. São Paulo, SP, Brasil
publishDate 2011
dc.date.issued.fl_str_mv 2011
dc.date.accessioned.fl_str_mv 2014-10-03T18:50:40Z
dc.date.available.fl_str_mv 2014-10-03T18:50:40Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv CORREA, A. B. G. et al. C7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma. Viruses, v. 3, n. 7, p. 1041-1058, 2011.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/8497
dc.identifier.issn.none.fl_str_mv 1999-4915
10.3390/v3071041
identifier_str_mv CORREA, A. B. G. et al. C7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma. Viruses, v. 3, n. 7, p. 1041-1058, 2011.
1999-4915
10.3390/v3071041
url https://www.arca.fiocruz.br/handle/icict/8497
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/8497/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/8497/2/Correia%20ABG%20C7a%20a%20Biphosphinic....pdf
https://www.arca.fiocruz.br/bitstream/icict/8497/3/Correia%20ABG%20C7a%20a%20Biphosphinic....pdf.txt
bitstream.checksum.fl_str_mv 7d48279ffeed55da8dfe2f8e81f3b81f
005cdd6045b4745755308b3f78929ee9
7d16bcc83602c2e7bffdae335c6e31de
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009064302477312